Forehan Simon
Royal Melbourne Hospital and the Royal Women's Hospital, Victoria, Australia.
Aust Fam Physician. 2012 Aug;41(8):578-81.
Thyroid hormone plays a critical role in fetal development. In pregnancy, increased thyroid hormone synthesis is required to meet fetal needs, resulting in increased iodine requirements.
This article outlines changes to thyroid physiology and iodine requirements in pregnancy, pregnancy specific reference ranges for thyroid function tests and detection and management of thyroid conditions in pregnancy.
Thyroid dysfunction affects 2-3% of pregnant women. Pregnancy specific reference ranges are required to define thyroid conditions in pregnancy and to guide treatment. Overt maternal hypothyroidism is associated with adverse pregnancy outcomes; thyroxine treatment should be commenced immediately in this condition. Thyroxine treatment has also been shown to be effective for pregnant women with subclinical hypothyroidism who are thyroid peroxidase antibody positive. Gestational thyrotoxicosis needs to be differentiated from Graves disease and rarely requires thionamide treatment. Postpartum thyroiditis most commonly presents with isolated hypothyroidism but a biphasic presentation and isolated hyperthyroidism can occur: a high index of suspicion is warranted for diagnosis.
甲状腺激素在胎儿发育中起关键作用。在孕期,需要增加甲状腺激素合成以满足胎儿需求,从而导致碘需求量增加。
本文概述了孕期甲状腺生理及碘需求的变化、孕期甲状腺功能检查的特定参考范围以及孕期甲状腺疾病的检测与管理。
甲状腺功能障碍影响2%至3%的孕妇。需要孕期特定参考范围来界定孕期甲状腺疾病并指导治疗。明显的母体甲状腺功能减退与不良妊娠结局相关;在此情况下应立即开始甲状腺素治疗。甲状腺素治疗对甲状腺过氧化物酶抗体阳性的亚临床甲状腺功能减退孕妇也已证明有效。妊娠期甲状腺毒症需要与格雷夫斯病相鉴别,且很少需要硫酰胺类药物治疗。产后甲状腺炎最常见表现为单纯性甲状腺功能减退,但也可出现双相表现及单纯性甲状腺功能亢进:诊断时需高度怀疑。